Stada falls for second day on Serbian news; Watson, Amphastar hit with patent lawsuit;

@FiercePharma: Chinese drugmakers turn up heat on India. Story | Follow @FiercePharma

> Stada Arzneimittel fell again in Frankfurt trading after writing down €97 million ($131.4 million) in unpaid bills from Serbian pharmaceutical wholesalers. Report

> Watson Pharmaceuticals ($WPI) has confirmed that Momenta Pharmaceuticals and Sandoz have filed suit against it and Amphastar Pharmaceuticals over a generic version of Lovenox. Watson release

> GlaxoSmithKline ($GSK) reps gave a public presentation on a wind turbine proposal for Montrose as part of a consultation on an £8 million plan for two 400-ft towers in Scotland. More

> The San Diego Sheriff's Department will re-examine the cell phone of the girlfriend of Medicis Pharmaceuticals CEO Joseph Shacknai with a new Windows-based operating system. Police originally determined she hanged herself at Shacknai's mansion. News

> The FDA has advised users of epinephrine inhalers containing chlorofluorocarbons to get a prescription for a replacement product. The inhalers, sold as Primatene Mist, cannot be made or sold after Dec. 31. FDA release

> Eleven Biotherapeutics has tapped former Taligen Therapeutics chief Abbie Celniker to be its new CEO. Article

Biotech News

@FierceBiotech: Good read. MT @ScottKirsner: Things entrepreneurs say that prevent investors from taking them seriously. Article | Follow @FierceBiotech

@JohnCFierce: Good to see Ambrx, Fierce 15 class of 2005, doing well. String of deals helped finance co. And BMS is a good partner. Report | Follow @JohnCFierce

@RyanMFierce: See who's betting big on a new cardiac device (via @FierceMedDev). Story | Follow @RyanMFierce

@MaureenFierce: Study: Removing cholesterol from HIV boosts second immune response. Report | Follow @MaureenFierce

@FierceMedDev: Former Wright exec takes reins at Intrinsic. Piece | Follow @FierceMedDev

> Ambrx banks $24M BMS check as it adds two new development deals. Story

> New study debunks longevity link for Sirtris's sexy sirtuins. Item

Vaccines News

> RXi licences ovarian cancer vax. Item

> Researchers: Whooping cough vaccine fades after 3 years. Story 

> Study: Vaccinating children against flu cuts ER visits. Article

> Sanofi aims for acne vaccine in new pact. News

Manufacturing News

> Pfizer's Grange Castle to be QC mecca. Story

> Rx-360 launch reinforces benefits of shared audits. News

> Chinese drugmakers turn up heat on India. Article

> With help from state, GSK adds jobs in Montana. Report

> DHL jockeys for pharma logistics biz in China. Item

> West-Ward sees shortages as 'major opportunity.' Report

And Finally... Administering cannabinoids after a traumatic event blocks the development of PTSD-like symptoms in rats, according to a new study conducted at the University of Haifa. Release

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.